135 related articles for article (PubMed ID: 38151295)
1. Clinical Significance of Multi-Cancer Genome Profiling: Data from a Single Hospital in Japan.
Aoyama R; Nishikubo H; Kawabata K; Kanei S; Yamamoto Y; Nishimura S; Yashiro M
Cancer Genomics Proteomics; 2024; 21(1):79-87. PubMed ID: 38151295
[TBL] [Abstract][Full Text] [Related]
2. First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.
Matsubara J; Mukai K; Kondo T; Yoshioka M; Kage H; Oda K; Kudo R; Ikeda S; Ebi H; Muro K; Hayashi R; Tokudome N; Yamamoto N; Muto M
JAMA Netw Open; 2023 Jul; 6(7):e2323336. PubMed ID: 37459099
[TBL] [Abstract][Full Text] [Related]
3. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
Kanai M
Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
[TBL] [Abstract][Full Text] [Related]
4. An approach for improvement of the accuracy of cancer gene panel testing.
Imoto K; Yamamoto H; Ohkawa C; Shimada N; Ikuzawa R; Takeda H; Ohhara T; Kojima Y; Furuya N; Motoyoshi A; Migita O; Kuga A; Keira T; Wakamatsu H; Sato T; Oike N; Koike J; Yamano Y; Sunakawa Y
Int J Clin Oncol; 2024 May; 29(5):571-581. PubMed ID: 38472663
[TBL] [Abstract][Full Text] [Related]
5. Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan.
Tang W; Hanada K; Motoo Y; Sakamaki H; Oda T; Furuta K; Abutani H; Ito S; Tsutani K
J Med Econ; 2023; 26(1):614-626. PubMed ID: 37073487
[TBL] [Abstract][Full Text] [Related]
6. Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy.
Yoshii Y; Okazaki S; Takeda M
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440540
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Comprehensive Genomic Profiling Tests for Gastrointestinal Cancers: Experience from Tokushima University Hospital.
Sato Y; Okada Y; Fujino Y; Kawaguchi T; Kida Y; Mitsui Y; Tanaka H; Tomonari T; Kitamura S; Okamoto K; Kawano Y; Miyamoto H; Sogabe M; Takayama T
J Med Invest; 2023; 70(1.2):154-159. PubMed ID: 37164713
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.
Ishikawa M; Nakamura K; Kawano R; Hayashi H; Ikeda T; Saito M; Niida Y; Sasaki J; Okuda H; Ishihara S; Yamaguchi M; Shimada H; Isobe T; Yuza Y; Yoshimura A; Kuroda H; Yukisawa S; Aoki T; Takeshita K; Ueno S; Nakazawa J; Sunakawa Y; Nohara S; Okada C; Nishimiya K; Tanishima S; Nishihara H
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672586
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreaticobiliary Cancer Aiming for a Comprehensive Genome Profile.
Hijioka S; Nagashio Y; Maruki Y; Kawasaki Y; Takeshita K; Morizane C; Okusaka T
Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046493
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)].
Kumaki Y; Takahashi K; Mitsumura T; Yokobori J; Takamine E; Ishibashi E; Sakashita H; Ishikawa T; Ono H; Ban D; Kudo A; Oshima N; Nakagawa T; Kimura K; Kubota K; Onishi I; Tanabe M; Uetake H; Miyake S; Ikeda S
Gan To Kagaku Ryoho; 2019 Nov; 46(11):1715-1719. PubMed ID: 31748480
[TBL] [Abstract][Full Text] [Related]
11. Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.
Higashigawa S; Matsubayashi H; Kiyozumi Y; Kado N; Nishimura S; Oishi T; Sugino T; Fushiki K; Shirasu H; Yasui H; Mamesaya N; Fukuzaki N; Kunitomo K; Horiuchi Y; Kenmotsu H; Serizawa M
Jpn J Clin Oncol; 2022 May; 52(6):599-608. PubMed ID: 35411369
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.
Kondo T; Matsubara J; Quy PN; Fukuyama K; Nomura M; Funakoshi T; Doi K; Sakamori Y; Yoshioka M; Yokoyama A; Tamaoki M; Kou T; Hirohashi K; Yamada A; Yamamoto Y; Minamiguchi S; Nishigaki M; Yamada T; Kanai M; Matsumoto S; Muto M
Cancer Sci; 2021 Jan; 112(1):296-304. PubMed ID: 33007138
[TBL] [Abstract][Full Text] [Related]
13. Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study.
Normanno N; De Luca A; Abate RE; Morabito A; Milella M; Tabbò F; Curigliano G; Masini C; Marchetti P; Pruneri G; Guarneri V; Frassineti GL; Fasola G; Adamo V; Daniele B; Berardi R; Feroce F; Maiello E; Pinto C
Eur J Cancer; 2023 Jul; 187():174-184. PubMed ID: 37167765
[TBL] [Abstract][Full Text] [Related]
14. [Additional Remarks on the Issue of Cancer Genomic Medicine-Focusing on Medical Insurance Issues].
Nishihara H
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1011-1013. PubMed ID: 36156029
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.
Aoyagi Y; Kano Y; Tohyama K; Matsudera S; Kumaki Y; Takahashi K; Mitsumura T; Harada Y; Sato A; Nakamura H; Sueoka E; Aragane N; Kimura K; Onishi I; Takemoto A; Akahoshi K; Ono H; Ishikawa T; Tokunaga M; Nakagawa T; Oshima N; Nakamura R; Takagi M; Asakage T; Uetake H; Tanabe M; Miyake S; Kinugasa Y; Ikeda S
PLoS One; 2022; 17(3):e0266112. PubMed ID: 35358259
[TBL] [Abstract][Full Text] [Related]
16. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
[TBL] [Abstract][Full Text] [Related]
17. Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Takeda M; Takahama T; Sakai K; Shimizu S; Watanabe S; Kawakami H; Tanaka K; Sato C; Hayashi H; Nonagase Y; Yonesaka K; Takegawa N; Okuno T; Yoshida T; Fumita S; Suzuki S; Haratani K; Saigoh K; Ito A; Mitsudomi T; Handa H; Fukuoka K; Nakagawa K; Nishio K
Oncologist; 2021 Apr; 26(4):e588-e596. PubMed ID: 33325566
[TBL] [Abstract][Full Text] [Related]
18. Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.
Hagio K; Kikuchi J; Takada K; Tanabe H; Sugiyama M; Ohhara Y; Amano T; Yuki S; Komatsu Y; Osawa T; Hatanaka KC; Hatanaka Y; Mitamura T; Yabe I; Matsuno Y; Manabe A; Sakurai A; Ishiguro A; Takahashi M; Yokouchi H; Naruse H; Mizukami Y; Dosaka-Akita H; Kinoshita I
Cancer Sci; 2023 Aug; 114(8):3385-3395. PubMed ID: 37208840
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
[TBL] [Abstract][Full Text] [Related]
20. Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies.
Matsuo M; Hashimoto K; Kogo R; Jiromaru R; Hongo T; Manako T; Nakagawa T
In Vivo; 2023; 37(5):2147-2154. PubMed ID: 37652518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
